EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, EZH2, the catalytic subunit of PRC2, is overexpressed in CML leukemia-initiating cells (LICs), and its depletion in LICs results in decreased capacity to form secondary leukemia upon transplantation in a murine model [189].